Adherence to antiretroviral treatment among pregnant and postpartum HIV-infected women

AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV

Volumn 20, Issue 8, 2008, Pages 958-968

  Mellins, C A ^a   Chu, C ^b   Malee, K ^c   Allison, S ^d   Smith, R ^e   Harris, L ^f   Higgins, A ^a   Zorrilla, C ^g   Landesman, S ^h   Serchuck, L ⁱ   Larussa, P ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b Clinical Trials & Surveys Corp   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^e UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^f TEXAS CHILDREN S HOSPITAL   (United States)

^g UNIVERSITY OF PUERTO RICO SCHOOL OF MEDICINE   (Puerto Rico)

^h STATE UNIVERSITY OF NEW YORK   (United States)

ⁱ EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

Adherence; Antiretroviral treatment; HIV; Pregnancy; Women

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCOME; MAJOR CLINICAL STUDY; PREGNANCY; PRIORITY JOURNAL; PUERPERIUM; SELF REPORT; SOCIAL STATUS; THIRD TRIMESTER PREGNANCY; VIRUS LOAD; VIRUS TRANSMISSION;

ADOLESCENT; ADULT; ANTI-RETROVIRAL AGENTS; FEMALE; HIV INFECTIONS; HUMANS; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MEDICATION ADHERENCE; POSTPARTUM PERIOD; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRENATAL CARE; UNITED STATES;

EID: 51349116558     PISSN: 09540121     EISSN: 13600451     Source Type: Journal    
DOI: 10.1080/09540120701767208     Document Type: Article

References (55)

1. Abrams, E.J., & Nicholas, S.W. (1998). Optimism at the millennium's end: The outlook for pediatric HIV infection. Insights in HIV Disease Management, 6, 79-88.
2. Adult AIDS Clinical Trials Group. (2006a). Lab manual. Retrieved September, 2006, from http://aactg.s-3.com/immlab.htm
3. Adult AIDS Clinical Trials Group. (2006b). Lab manual. Retrieved September, 2006, from http://aactg.s-3.com/virlab.htm
4. Ajzen, I., & Fishbein, M. (1980). Understanding attitudes and predicting social behavior. Englewood Cliffs, NJ: Prentice-Hall.
5. Armitage, P. (1955). Tests for linear trends in proportions and frequencies. Biometrics, 11, 375-386.
6. Bangsberg, D.R. (2006). Less than 95% adherence to nonnucleioside reverse-transcriptase inhibitor therapy can lead to viral suppression. Clinical Infectious Diseases, 43, 939-941.
7. Bangsberg, D.R., & Deeks, S.G. (2002). Is average adherence to HIV antiretroviral therapy enough? Journal of General Internal Medicine, 17, 812-813.
8. Becker, M.H. (1974). The health belief model and personal health behavior. Health Education Monographs, 2, 324-508.
9. Becker, M.H., Drachman, R.H., & Kirscht, J.P. (1972). Predicting mothers' compliance with pediatric medical regiments. Medical Care, 81, 843-854.
10. Bing, E.G., Burnam, M.A., Longshore, D., Fleishman, J.A., Sherbourne, C.D., London, A.S., et al. (2001). Psychiatric disorders and drug use among HIV-infected adults in the US. Archives of General Psychiatry, 58, 721-728.
11. Catz, S.L., Kelly, J.A., Benotsch, E., & McAuliffe, T.L. (2000). Patterns, correlates, and barriers to medication adherence among persons prescribed new treatments for HIV disease. Health Psychology, 19, 124-133.
12. Centers for Disease Control and Prevention. (1993). Revised classification for HIV infection and expanded surveillance case definition of AIDS among adolescents and adults. Morbidity and Mortality Weekly Report, 41(RR-17), 1-19.
13. Centers for Disease Control and Prevention. (2006). CDC HIV/AIDS fact sheet. Mother-to-child (perinatal) HIV transmission and prevention, 2006. Retrieved on April 10, 2007 from: http://www.cdc.gov/hiv
14. Chesney, M.A., (2003). Adherence to HAART regimens. AIDS Patient Care STDs, 17, 169-177.
15. Chesney, M.A., Ickovics, J.R., Chambers, D.B., Gifford, A.L., Neidig, J., Zwickl, B., et al. (2000). Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG adherence Instruments. AIDS Care, 12, 255-266.
16. Ciambrone, D., Loewenthal, H.G., Bazerman, L.B., et al. (2006). Adherence among women with HIV infection in Puerto Rico: The potential use of modified directly observed therapy (MDOT) among pregnant and postpartum women. Women & Health, 44, 61-77.
17. 2 tests. Biometrics, 10, 417-451.
18. Conover, C.J., Ettner, S.L., Weaver, M., Flynn, P.M., & Porto, J.V. (2004). HIV/AIDS treatment adherence health outcomes and cost study group. Economic evaluations of HIV treatment and health research with people diagnosed with HIV infection and co-occuring mental health and substance use disorders. AIDS Care, 16(Suppl. 1), S121-S136.
19. Demas, P.A., Thea, D.M., Weedon, J., McWayne, J., Bamji, M., Lambert, G., et al. (2005). Adherence to Zidovudine for the prevention of perinatal transmission in HIV-infected women: The impact of social network factors, side effects and perceived treatment efficacy. Women & Health, 42, 99-115.
20. Department of Health and Human Services. (2006). The adult guidelines: Panel on antiretroviral guidelines for adults and adolescents. Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents (pp. 1-113). Retrieved October 10, 2006, from http://www.aidsinfo.nih.gov/ ContentFiles/AdultandAdolescentsGL.pdf
21. Desai, N. & Mathur, M. (2003). Selective transmission of multidrug resistant HIV to a newborn related to poor maternal adherence. Sexually Transmitted Infections, 79, 419-421.
22. Ewart, C.K. (1991). Social Action Theory for a public health psychology. American Psychologist, 46, 931-946.
23. Fisher, R.A. Statistical methods for research workers (originally published 1925). Edinburgh: Oliver and Boyd (1934).
24. Hammer, S.M., Squires, K.E., Hughes, M.D., Grimes, J.M., Demeter, L.M., et al. (1997). A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. New England Journal of Medicine, 337, 725-733.
25. Havens, J.F. & Mellins, C.A. (2008). Psychiatric aspects of HIV/AIDS in childhood and adolescence. In M. Rutter & E. Taylor (Eds.), Child and adolescent psychiatry (5th ed.). Oxford, UK: Blackwell.
26. Holstad, M., DiIorio, C., & Magowe, M. (2006). Motivating HIV-positive women to adhere to antiretroviral therapy and risk reduction behavior: The KHARMA project. The Online Journal of Issues in Nursing, 11, 5.
27. Ickovics, J.R., Wilson, T.E., Royce, R.A., Minkoff, H.L., Fernandez, M.I., Fox-Tierney, R., et al. (2002). Perinatal Guidelines Evaluation Group. Prenatal and postpartum zidovudine adherence among pregnant women with HIV: Results of a MEMS substudy from the Perinatal Guidelines Evaluation Project. Journal of Acquired Immune Deficiency Syndromes, 30, 311-315.
28. Katzenstein, D.A. (1997). Adherence as a particular issue with protease inhibitors. Journal of the Association of Nurses in AIDS Care, 8(Suppl. 1), 10-17.
29. Kuhn, L., Stein, Z., & Susser, M. (2004). Preventing mother-to-child HIV transmission in the new millennium: the challenge of breast feeding. Paediatric and Perinatal Epidemiology, 18, 10-16
30. Kuhn, L., Thomas, P.A., Singh, T., & Tsai, W.Y. (1998). Long-term survival of children with HIV infection in New York City: Estimates from population-based surveillance data. American Journal of Epidemiology, 147(9), 846-854.
31. Laine, C., Newschaffer, C.J., Zhang, D., Cosler, L., Hauck, W.W., & Turner, B.J. (2000). Adherence to antiretroviral therapy by pregnant women infected with human immunodeficiency virus: A pharmacy claims-based analysis. Obstetrics & Gynecology, 95, 167-173.
32. Ley, P. (1988). Communicating with patients: Improving communication, satisfaction and compliance (pp. 61-63). NY: Chapman and Hall.
33. Liu, H., Longshore, D., Williams, J.K., Rivkin, I., Loeb, T., Warda, U.S., Carmona, J., & Wyatt, G. (2006). Substance abuse and medication adherence among HIV-postiive women with histories of child sexual abuse. AIDS and Behavior, 10, 279-286.
34. Mellins, C., Kang, E., Leu, C., Havens, J., & Chesney, M. (2003). Longitudinal study of mental health and psychosocial predictors of medical treatment adherence in mothers living with HIV disease. AIDS Patient Care and STDs, 17, 407-415.
35. Mellins, R.B., Zimmerman, B., & Clark, N.M. (1992). Patient compliance: Are we wasting our time and don't know it? Editorial in American Review of Respiratory Diseases, 146, 1376-1377.
36. Navas-Nacher, E.L., Read, J.S., Leighty, R.M., Tuomala, R.E., Zorrilla, C.D., Landesman, S., et al. (2006). Mode of delivery and postpartum HIV-1 disease progression: The Women and Infants Transmission Study. AIDS, 20, 429-436.
37. Park, H., Tochuku, A., & Grigoriu, A. (2007, March) The dynamics of adherence to HAARTin HIV-infected pregnant women. Abstract presented at the NIMH/IAPAC International Conference on HIV Treatment and Adherence, Jersey City, NJ.
38. Paterson, D.L., Swindells, S., Mohr, J., Brester, M., Vergis, E.N., Squier, C., et al. (2000). Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Annals of Internal Medicine, 133, 21-30.
39. Piacenti, F.J. (2006). An update and review of antiretroviral therapy. Pharmacotherapy, 16, 1111-1133.
40. Remien, R.H., Exner, T.E., Morin, S.F., Ehrhardt, A.A., Johnson, M.O., Correale, J., Marhefka, S., Kirshenbaum, S.B., Weinhardt, L.S., Rotheram-Borus, R.J., Catz, S., Gore-Felton, C., Chesney, M., Kelly, J., and the NIMH Healthy Living Project Team (2007). Medication adherence and sexual risk behavior among HIV-infected adults: Implications for transmission of resistant virus. AIDS and Behavior, 11(5), 663-675.
41. Rodriguez Vaz, M.J., Oliveira Barros, S.M., Palacios R., et al. (2007). HIV-infected pregnant women have greater adherence with antiretroviral drugs than non-pregnant women. International Journal of STD & AIDS, 18, 28-32.
42. Sheon, A.R., Fox, H.E., Rich, K.C., Stratton, P., Diaz, C., Tuomala, R., et al. (1996). The Women and Infants Transmission Study (WITS) of maternal-infant HIV transmission: Design, methods, and baseline data. Journal of Women's Health, 5, 69-78.
43. Simoni, J.M., Frick, P.A., Pantalone, D.W., & Turner, B.J. (2003). Antiretroviral adherence interventions: a review of current literature and ongoing studies. International AIDS Society, 11, 185-198.
44. Singh, V.L., Squier, C., Sivek, C., et al., (1996). Determinants of compliance with antiretroviral therapy in patients with human immunodeficiency virus: prospective assessment with implications for enhancing compliance. AIDS Care, 8, 261-269.
45. Stoff, D.M., Mitnick, L., & Kalichman, S. (2004). Research issues in the multiple diagnoses of HIV/AIDS, mental illness, and substance abuse. AIDS CARE, 16(Suppl. 1), S1-S5.
46. Tedaldi, E., Willard, S., Gilmore, J., Holdsworth, C., Dix-Lassiter, S., & Axelrod, P. (2002). Continuation of postpartum antiretroviral therapy in a cohort of women infected with human immunodeficiency virus. Journal of the Association of Nurse in AIDS Care, 13, 60-65.
47. Turner, B., Newschaffer, C., Zhang D., Cosler, L., & Hauck, W. (2000). Antiretroviral use and pharmacy-based measurement of adherence in HIV-infected women post-partum. Medical Care, 38, 911-925.
48. Uldall, K.K., Palmer, N.B., Whetten K., & Mellins, C. (2004). HIV/AIDS treatment adherence health outcomes and cost study group. Adherence in people living with HIV/AIDS, mental illness and chemical dependency: A review of the literature. AIDS CARE, 16(Suppl. 1), S71-S96.
49. UNAIDS. (2006). AIDS epidemic update. Retrieved December, 2006, from http://www.unaids.org
50. Wagner, G., & Rabkin, J.G. (2000). Measuring medication adherence: Are missed doses reported more accurately then perfect adherence? AIDS Care, 12, 405-408.
51. Warner, L.A., Wenhui, W., McSpiritt, E., Sambamoorthi, U., & Crystal, S. (2003). Ante- and portpartum substance abuse treatment and antiretroviral therapy among HIV-infected women on Medicaid. Journal of the American Medical Women's Association, 58(3), 143-153.
52. Williams, A., Fennie, K., Bova, C., Burgess, J., Danvers, K., & Kieckhaus, K. (2006). Home visits to improve adherence to highly active antiretroviral therapy: A randomized controlled trial. Journal of Acquired Immune Deficiency Syndrome, 42, 314-321.
53. Wood, S.A., Tobias, C., & McCree, J. (2004). Medication adherence for HIV positive women caring for children: in their own words. AIDS Care, 16(7), 909-913.
54. Zeger, S.L., & Liang, K.Y. (1986). Longitudinal data analysis for discrete and continuous outcomes. Biometrics, 42, 121-130.
55. Zorrilla, C.D., Santiago, L.E., Knubson, D., Liberatore, K., Estronza, G., Colon, O., et al. (2003). Greater adherence to HAART between pregnant versus nonpregnant women living with HIV. Cellular & Molecular Biology, 49, 1187-1192.